Astera Cancer Center

East Brunswick, New Jersey 08816

1 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumors, Diffuse Large B-cell Lymphoma (DLBCL), Epitheliod Sarcoma (ES), Follicular Lymphoma, Follicular Lymphoma (FL), Mesothelioma, Metastatic Colorectal Cancer, Non-Hodgkin Lymphoma (NHL), Prostate Cancer, Refractory Follicular Lymphoma, Refractory Hematologic Malignancy, Relapsed Hematologic Malignancy

Studies at this site

• Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC — Recruiting now
• A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. — Running, not enrolling
• A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study — Completed
• Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC — Stopped early
• A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer. — Withdrawn before enrolling